These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 12766699)

  • 1. Global Benefit-risk Evaluation of Antidepressant Action: Comparison of Pooled Data for Venlafaxine, SSRIs, and Placebo.
    Entsuah R; Gao B
    CNS Spectr; 2002 Dec; 7(12):882-888. PubMed ID: 12766699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin and Norepinephrine Reuptake Inhibitors.
    Shelton RC
    Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine.
    Entsuah R; Gorman JM
    J Psychiatr Res; 2002; 36(3):111-8. PubMed ID: 11886688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
    Nemeroff CB; Thase ME;
    J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of depression in the elderly: a review of the recent literature on the efficacy of single- versus dual-action antidepressants.
    Mukai Y; Tampi RR
    Clin Ther; 2009 May; 31(5):945-61. PubMed ID: 19539096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Priorities in treating depression only.
    Lam RW
    Int J Psychiatry Clin Pract; 2004; 8 Suppl 1():25-9. PubMed ID: 24930686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression.
    Rudolph RL; Feiger AD
    J Affect Disord; 1999 Dec; 56(2-3):171-81. PubMed ID: 10701474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the efficacy and tolerability of venlafaxine.
    Dierick M
    Eur Psychiatry; 1997; 12 Suppl 4():307s-13s. PubMed ID: 19698585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of antidepressants.
    Kasper S; Fuger J; Möller HJ
    Drugs; 1992; 43 Suppl 2():11-22; discussion 22-3. PubMed ID: 1378369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission from depression : a review of venlafaxine clinical and economic evidence.
    Han D; Wang EC
    Pharmacoeconomics; 2005; 23(6):567-81. PubMed ID: 15960553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Metabolites of Antidepressants in the Treatment of Depression.
    Rudorfer MV; Potter WZ
    CNS Drugs; 1997 Apr; 7(4):273-312. PubMed ID: 27520753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of venlafaxine in rational antidepressant therapy.
    Feighner JP
    J Clin Psychiatry; 1994 Sep; 55 Suppl A():62-8; discussion 69-70, 98-100. PubMed ID: 7961545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials.
    Katz IR; Reynolds CF; Alexopoulos GS; Hackett D
    J Am Geriatr Soc; 2002 Jan; 50(1):18-25. PubMed ID: 12028242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial.
    van Kerkhoven LA; Laheij RJ; Aparicio N; De Boer WA; Van den Hazel S; Tan AC; Witteman BJ; Jansen JB
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):746-52; quiz 718. PubMed ID: 18424191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
    Keller MB; Trivedi MH; Thase ME; Shelton RC; Kornstein SG; Nemeroff CB; Friedman ES; Gelenberg AJ; Kocsis JH; Dunner DL; Hirschfeld RM; Rothschild AJ; Ferguson JM; Schatzberg AF; Zajecka JM; Pedersen RD; Yan B; Ahmed S; Musgnung J; Ninan PT
    J Clin Psychiatry; 2007 Aug; 68(8):1246-56. PubMed ID: 17854250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venlafaxine: a structurally unique and novel antidepressant.
    Morton WA; Sonne SC; Verga MA
    Ann Pharmacother; 1995 Apr; 29(4):387-95. PubMed ID: 7633018
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.